middl
east
respiratori
syndrom
coronaviru
merscov
emerg
arabian
gulf
region
epicentr
saudi
arabia
host
hajj
world
largest
mass
gather
transmiss
merscov
event
could
lead
rapid
worldwid
dissemin
therefor
studi
frequenc
virus
caus
infl
uenzalik
ill
ili
among
particip
randomis
control
trial
hajj
recruit
pilgrim
saudi
arabia
australia
qatar
fi
rst
day
hajj
follow
close
four
day
nasal
swab
collect
pilgrim
develop
ili
respiratori
virus
detect
use
multiplex
rtpcr
ili
occur
pilgrim
mean
age
year
male
receiv
infl
uenza
vaccin
prehajj
forti
two
pilgrim
laboratoryconfi
rmed
viral
infect
rhinoviru
infl
uenza
adenoviru
human
coronaviru
parainfl
uenza
viru
parainfluenza
viru
dual
infect
merscov
detect
sampl
rhinoviru
commonest
caus
ili
among
hajj
pilgrim
infect
control
appropri
vaccin
necessari
prevent
transmiss
respiratori
virus
hajj
mass
gather
respiratori
tract
infect
rti
includ
influenza
import
health
hazard
among
travel
incid
infl
uenza
return
febril
travel
subtrop
tropic
region
askl
h
h
et
al
belderok
et
al
davi
x
et
al
geosentinel
data
pandem
influenza
show
detect
travelrel
case
could
reliabl
indic
sustain
infl
uenza
transmiss
within
exposur
countri
may
aid
plan
control
measur
davi
x
et
al
mass
gather
event
hajj
pilgrimag
olymp
game
footbal
world
cup
known
amplifi
risk
transmiss
respiratori
virus
includ
escal
pandem
infl
uenza
blyth
c
c
et
al
haworth
e
et
al
zepedalopez
h
et
al
instanc
postul
mass
event
took
place
iztapalapa
mexico
spark
rapid
global
dissemin
infl
uenza
zepedalopez
h
et
al
hajj
million
pilgrim
assembl
mecca
citi
move
bodi
mina
small
valley
outskirt
mecca
live
tent
share
depend
size
person
interplay
multitud
factor
includ
sever
crowd
limit
facil
time
person
hygien
particul
microbiolog
air
pollut
hajj
increas
risk
acquisit
respiratori
virus
fold
hame
et
al
haworth
e
et
al
emerg
middl
east
respiratori
syndrom
coronaviru
merscov
gulf
region
epicentr
saudi
arabia
rais
major
concern
possibl
homebound
pilgrim
spread
merscov
global
rashid
h
et
al
limit
virolog
syndrom
surveil
data
hajj
show
hajjassoci
transmiss
merscov
viru
detect
pilgrim
visit
mecca
medina
umrah
pilgrimag
devi
j
p
et
al
health
protect
agenc
hpa
uk
novel
coronaviru
investig
team
two
studi
attempt
assess
preval
merscov
influenza
among
pilgrim
hajj
studi
provid
time
valuabl
data
methodolog
limit
one
provid
airportbas
surveil
data
therefor
reflect
true
hajj
epidemiolog
although
conduct
hajj
site
studi
array
bacteri
viral
pathogen
involv
one
travel
group
pilgrim
marseil
therefor
may
generalis
pilgrim
current
report
present
data
attack
rate
common
respiratori
virus
among
symptomat
pilgrim
saudi
arabia
australia
qatar
particip
larg
trial
assess
effi
caci
facemask
respiratori
infect
includ
merscov
hajj
protocol
studi
publish
detail
elsewher
wang
et
al
breifli
pilgrim
saudi
arabia
australia
qatar
recruit
largescal
clusterrandomis
control
trial
assess
effi
caci
facemask
prevent
respiratori
virus
includ
infl
uenza
merscov
among
hajj
pilgrim
report
analys
data
symptomat
pilgrim
hajj
conveni
place
individu
tent
accommod
hajj
pilgrim
saudi
arabia
australia
qatar
randomli
assign
supervis
use
facemask
versu
standard
infect
control
measur
recommend
saudi
ministri
health
moh
everi
member
particip
tent
elig
particip
studi
morn
afternoon
fi
rst
day
hajj
th
octob
research
team
member
consist
physician
train
medic
student
explain
studi
pilgrim
tent
invit
age
year
older
particip
studi
voluntarili
particip
consent
ask
complet
baselin
questionnair
th
octob
includ
contact
detail
relev
demograph
vaccin
histori
clinic
inform
includ
current
respiratori
symptom
durat
preexist
medic
condit
particip
provid
diari
uniqu
barcod
number
identifi
cation
pilgrim
record
dairi
sever
outcom
new
continu
infl
uenzalik
ill
ili
diari
collect
conclus
hajj
th
octob
pilgrim
age
year
andor
preexist
medic
ill
chronic
lung
heart
kidney
liver
neuromuscular
metabol
immunocompromis
condit
defi
ned
risk
individu
sinc
higher
risk
develop
sever
complic
infl
uenza
infect
day
research
team
member
visit
tent
activ
search
pilgrim
develop
ili
defi
ned
subject
proven
fever
least
one
respiratori
symptom
cough
sore
throat
rhinorrhoea
nasopharyng
np
swab
throat
swab
np
swab
possibl
taken
pilgrim
ili
train
team
member
use
copan
flock
swab
place
univers
transport
medium
copan
italia
brescia
itali
swab
frozen
within
day
collect
store
temperatur
test
westmead
hospit
new
south
wale
australia
ship
process
took
month
swab
could
move
jeddah
airport
cold
storag
facil
repair
certifi
ed
effect
nucleic
acid
extract
perform
use
qiagen
biorobot
ez
instrument
qiagen
valencia
ca
amplifi
cation
carri
use
roch
lc
roch
diagnost
gmbh
mannheim
germani
realtim
instrument
respiratori
virus
detect
use
realtim
multiplex
rtpcr
assay
target
human
coronavirus
influenza
infl
uenza
b
respiratori
syncyti
viru
parainfl
uenza
virus
human
metapneumoviru
rhinoviru
enteroviru
adenovirus
describ
detail
elsewher
ratnamohan
v
et
al
gaunt
e
r
et
al
merscov
assay
target
region
upstream
e
gene
upe
also
perform
describ
previous
corman
v
et
al
total
pilgrim
recruit
tent
follow
peak
period
hajj
figur
recruit
pilgrim
male
saudi
arabia
australia
qatar
preval
ili
among
recruit
pilgrim
np
swab
collect
symptomat
pilgrim
initi
throat
swab
collect
two
particip
eventu
np
swab
collect
figur
age
mean
year
particip
demograph
characterist
describ
tabl
accord
countri
origin
twenti
two
report
ili
consid
risk
acquir
respiratori
infect
due
age
year
coexist
chronic
medic
condit
chronic
respiratori
diseas
diabet
cardiac
diseas
renal
disord
symptomat
pilgrim
report
receiv
infl
uenza
vaccin
hajj
uptak
infl
uenza
vaccin
among
australian
qatari
saudi
pilgrim
respect
sixti
pilgrim
fulfi
lled
ili
defi
nition
time
recruit
th
octob
fresh
new
case
ili
report
new
case
monday
th
tuesday
th
wednesday
th
figur
common
respiratori
symptom
sore
throat
follow
cough
runni
nose
symptomat
pilgrim
visit
clinic
health
care
centr
mecca
ili
rti
symptom
forti
two
pilgrim
laboratoryconfi
rmed
viral
infect
rhinoviru
infl
uenza
adenoviru
human
coronaviru
parainfluenza
viru
parainfluenza
viru
dual
infect
rhinovirusadenoviru
rhinovirushuman
coronaviru
tabl
rate
infl
uenza
vaccin
pilgrim
similar
unvaccin
pilgrim
versu
p
merscov
detect
sampl
studi
show
pointpreval
ili
among
pilgrim
saudi
arabia
australia
qatar
volunt
particip
studi
hajj
symptomat
pilgrim
laboratoryconfirm
viral
infect
compar
viru
detect
rate
among
french
pilgrim
hajj
rate
ili
lower
seen
french
pilgrim
year
howev
latter
subject
least
one
respiratori
symptom
unpublish
report
involv
malaysian
pilgrim
show
suffer
ili
hajj
preval
vari
accord
geograph
locat
within
mecca
dr
habsah
hasan
kelantan
malaysia
person
commun
declin
ili
rate
next
day
stay
mina
interest
unexpect
figur
signifi
canc
unexplain
stage
possibl
effect
facemask
use
mani
pilgrim
data
insuffici
support
refut
notion
studi
conduct
past
year
shown
preval
ili
among
hajj
pilgrim
vari
countri
origin
year
instanc
rashid
h
et
al
howev
pilot
studi
conduct
team
observ
australian
pilgrim
ili
hajj
howev
french
hajj
pilgrim
report
ili
gautret
p
et
al
hajj
malaysian
pilgrim
develop
ili
deri
z
z
et
al
dispar
explain
factor
differ
age
preval
underli
chronic
diseas
well
season
geograph
variat
respiratori
viru
circul
averag
age
among
particip
year
underli
chronic
diseas
contrast
situat
seen
french
pilgrim
whose
mean
age
year
chronic
underli
medic
condit
also
noteworthi
defi
nition
ili
defer
across
studi
merscov
detect
pilgrim
studi
corrobor
find
french
studi
saudi
airportbas
surveil
merscov
neither
identifi
ed
viru
among
pilgrim
attend
hajj
benkouiten
et
al
despit
absenc
laboratori
confi
rmed
merscov
among
hajj
pilgrim
spike
mer
case
occur
april
saudi
arabia
importantli
port
citi
jeddah
pilgrim
enter
leav
mecca
alghamdi
g
et
al
addit
malaysian
ministri
health
report
fatal
case
laboratoryconfi
rmed
merscov
infect
year
old
man
return
umrah
pilgrimag
end
march
patient
visit
camel
farm
drank
camel
milk
devi
j
p
et
al
anoth
laboratoryconfi
rmed
case
merscov
report
year
old
greek
man
return
jeddah
individu
report
contact
camel
regularli
visit
wife
hospitalis
jeddah
enter
fever
tsiodra
et
al
similarli
fi
rst
two
confirm
case
merscov
infect
north
america
report
us
healthcar
worker
age
year
respect
live
work
hospit
saudi
arabia
patient
mer
receiv
care
bialek
r
et
al
updat
indic
enhanc
surveil
urgent
requir
teas
modal
transmiss
explor
effect
prevent
measur
potenti
therapeut
intervent
commonest
caus
ili
studi
rhinoviru
detect
symptomat
pilgrim
similarli
rhinoviru
common
caus
ili
among
british
pilgrim
intern
pilgrim
arriv
middl
east
asia
africa
french
pilgrim
memish
z
et
al
addit
rhinoviru
infect
report
among
iranian
pilgrim
subsequ
among
nonhajj
travel
onset
pandem
infl
uenza
alborzi
et
al
jaureguiberri
et
al
although
rhinoviru
infect
usual
rel
mild
lead
hospitalis
patient
chronic
medic
condit
walker
e
et
al
attack
rate
influenza
viru
symptomat
pilgrim
hajj
wherea
preval
influenza
viru
among
french
pilgrim
year
observ
global
infl
uenza
activ
time
hajj
expert
opin
pilgrim
tropic
africa
might
introduc
viru
hajj
thu
facilit
spread
among
european
pilgrim
return
french
hajj
pilgrim
infl
uenza
year
influenza
pandem
preval
infl
uenza
viru
infect
includ
among
intern
hajj
pilgrim
memish
z
et
al
infl
uenza
attack
rate
report
saudi
arabian
british
iranian
hajj
pilgrim
alborzi
et
al
attack
rate
among
uk
pilgrim
differ
may
due
vari
methodolog
sampl
size
influenza
vaccin
uptak
season
variat
influenza
pilgrim
countri
origin
chang
season
hajj
happen
hajj
move
day
forward
gregorian
calendar
strength
studi
data
origin
larg
sampl
size
pilgrim
close
follow
peak
day
hajj
furthermor
time
site
recruit
followup
studi
conduct
main
hajj
spot
mina
intens
hajj
activ
present
repres
hajj
epidemiolog
studi
throat
swab
obtain
two
particip
ultim
np
swab
obtain
recent
studi
confi
rmed
nasal
swab
superior
detect
common
respiratori
virus
among
hajj
pilgrim
howev
nasal
nasopharyng
swab
shown
poor
detect
merscov
peopl
pneumonia
lower
respiratori
tract
sampl
sputum
prefer
bronchoalveolar
lavag
sampl
produc
better
yield
also
note
data
deriv
symptomat
patient
recruit
randomis
control
trial
asymptomat
individu
swab
effect
facemask
explor
trial
continu
wang
et
al
full
result
publish
requir
number
particip
obtain
summari
merscov
detect
target
popul
pilgrim
saudi
arabia
australia
qatar
peak
period
hajj
amongst
pilgrim
respiratori
symptom
rhinovirus
common
respiratori
virus
identifi
ed
sever
respiratori
virus
includ
influenza
adenoviru
coronavirus
parainfluenza
virus
also
detect
infect
control
measur
minimis
risk
transmiss
respiratori
virus
relev
vaccin
particularli
influenza
continu
method
prevent
transmiss
respiratori
virus
hajj
mass
gather
professor
robert
booy
dr
leon
heron
receiv
fund
baxter
csl
gsk
merck
novarti
pfi
zer
roch
romark
sanofi
pasteur
conduct
sponsor
research
travel
present
confer
consult
work
fund
receiv
direct
research
account
children
hospit
westmead
author
declar
confl
ict
interest
relat
work
ob
execut
trial
analys
data
prepar
fi
rst
draft
manuscript
hr
guarantor
studi
oversaw
implement
studi
contribut
data
analysi
manuscript
prepar
maf
mt
hb
nk
js
particip
data
collect
contribut
manuscript
lh
supervis
prepar
research
protocol
research
tool
jk
jt
respons
conduct
molecular
diagnost
test
heb
contribut
data
interpret
zam
contribut
studi
design
eh
contribut
studi
design
supervis
data
analysi
interpret
ech
ded
contribut
design
interpret
molecular
diagnost
test
aa
contribut
collect
analysi
interpret
data
rb
supervis
data
interpret
overseen
manuscript
revis
hajj
research
team
particip
data
collect
sort
logist
